Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

ANALYST COVERAGE

benchmark-maintains-buy-on-insw-(international-seaways)-feb-26,-2026

Benchmark Maintains Buy on INSW (International Seaways) Feb 26, 2026

Feb 27, 2026

Benchmark maintained a Buy on International Seaways (INSW) on February 26, 2026. The firm left its recommendation intact…

Read more
benchmark-maintains-buy-on-pgre-(paramount-group,-inc.)-feb-26,-2026

Benchmark Maintains Buy on PGRE (Paramount Group, Inc.) Feb 26, 2026

Feb 27, 2026

Benchmark maintained a Buy on PGRE on Feb 26, 2026, signaling continued analyst confidence despite no new price…

Read more
goldman-sachs-maintained-buy-on-loar-holdings-inc-(loar)-feb-26,-2026

Goldman Sachs Maintained Buy on Loar Holdings Inc (LOAR) Feb 26, 2026

Feb 27, 2026

Goldman Sachs maintained a Buy on Loar Holdings Inc. (LOAR) on Feb 26, 2026, a move that sets…

Read more
ubs-maintains-buy-on-kdp,-pt-raised-to-$36-feb-26-2026

UBS Maintains Buy on KDP, PT Raised to $36 Feb 26 2026

Feb 27, 2026

UBS maintained its Buy on Keurig Dr Pepper Inc. (KDP) on February 26, 2026 and raised the price…

Read more
ubs-maintains-neutral-on-penumbra-(pen)-feb-26,-2026

UBS Maintains Neutral on Penumbra (PEN) Feb 26, 2026

Feb 27, 2026

UBS maintained a Neutral rating on Penumbra, Inc. (PEN) on February 26, 2026, reiterating a $374 price target…

Read more
kymr:-kymera-therapeutics-maintained-outperform-by-rbc-capital-feb-26-2026

KYMR: Kymera Therapeutics Maintained Outperform by RBC Capital Feb 26 2026

Feb 27, 2026

RBC Capital maintained an Outperform rating on Kymera Therapeutics (KYMR) on February 26, 2026. This KYMR analyst rating…

Read more
william-blair-upgrades-lantheus-holdings-(lnth)-to-outperform-feb-26,-2026

William Blair Upgrades Lantheus Holdings (LNTH) to Outperform Feb 26, 2026

Feb 27, 2026

William Blair upgraded Lantheus Holdings, Inc. to Outperform on February 26, 2026, marking the most notable change in…

Read more
why-investors-rely-on-cnbc-pro

Why investors rely on CNBC Pro

Feb 27, 2026

This is part of a series of CNBC Pro articles designed to help you make the most of…

Read more
bofa-securities-upgrades-teladoc-health,-inc.-(tdoc)-to-buy-feb-26,-2026

BofA Securities Upgrades Teladoc Health, Inc. (TDOC) to Buy Feb 26, 2026

Feb 27, 2026

Bank of America Securities upgraded Teladoc Health, Inc. (TDOC) from Neutral to Buy on February 26, 2026. The…

Read more
morgan-stanley-maintains-overweight-on-vista-energy-(vist)-feb-26-2026

Morgan Stanley Maintains Overweight on Vista Energy (VIST) Feb 26 2026

Feb 27, 2026

VIST analyst rating: Morgan Stanley maintained Overweight on Vista Energy, S.A.B. de C.V. (VIST) on Feb 26, 2026,…

Read more
bank-of-america-maintains-buy-on-ebay-inc.-(ebay)-feb-26,-2026

Bank of America Maintains Buy on eBay Inc. (EBAY) Feb 26, 2026

Feb 27, 2026

Bank of America Securities maintained a Buy on eBay Inc. (EBAY) on February 26, 2026, marking the latest…

Read more
hall-of-fame-analyst-‘likely-out’-as-network-revamps-primetime-nfl-coverage

Hall of Fame analyst ‘likely out’ as network revamps primetime NFL coverage

Feb 26, 2026

Sports Published: Feb. 26, 2026, 2:50 p.m. Sunday Night Football hosts Jack Collinsworth, Tony Dungy and Rodney Harrison…

Read more
  1. Pages:
  2. «
  3. 1
  4. ...
  5. 24
  6. 25
  7. 26
  8. 27
  9. 28
  10. 29
  11. 30
  12. ...
  13. 378
  14. »

Posts pagination

Newer posts Page 1 … Page 27 … Page 378 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.